| 組別 | 藥物名稱 | 劑量 | 途徑 | 頻率 | 時間及備註 |
|---|---|---|---|---|---|
| 1 | NS | 20 mL | IV | D1, D8, D15 | 速度見備注 |
| Bleomycin | 30 mg | ||||
| 2 | NS | 250 mL | IVDRIP | D1-D5 | 速度見備注 |
| Cisplatin | 20 mg/M2 | ||||
| 3 | NS | 500 mL | IVDRIP | D1-D5 | 速度見備注 |
| Etoposide | 100 mg/M2 |
Bleomycin dose equivalence: 1,500 International Units is equivalent to 1.5 USP units and approximately equivalent to 1.5mg (by potency) or 1mg (by weight)
Frequency: 21 Days
Cycle: 3 cycles (4 cycles for high risk patients)
| Good Prognosis | Seminoma | Non-semninoma |
| Good prognosis | Any primary site and No non-pulmonary visceral metastases and Normal AFP, any ßhCG, any LDH 56% of non-seminoma 5-year PFS 90% 5-year OS 96% | esticular or retroperitoneal primary tumour
5-year PFS 89% 5-year OS 95% |
| Intermediate prognosis | Any primary site and Non-pulmonary visceral metastases and Normal AFP, any ßhCG, any LDH 10% of seminoma 5-year PFS 79% 5-year OS 72% | Testicular or retroperitoneal primary tumour
28% of non-seminoma 5-year PFS 78% 5-year OS 89% |
| Poor prognosis | No patients classified as poor prognosis | Mediastinal primary tumour any of:
16% of non-seminoma 5-year PFS 54% 5-year OS 67% |
Bleomycin:
Administer bleomycin (irritant):
over 10 minutes, flush with ~ 50 mL of sodium chloride 0.9%
Observe for hypersensitivity reaction especially during the first and second doses
Yypersensitivity reaction can occur with any dose of bleomycin regardless of whether a test dose has been administered.
Cisplatin:
Administer cisplatin (irritant):
via IV infusion over 60 minutes, flush with 100 mL of sodium chloride 0.9%, observe for hypersensitivity reactions which can increase with the number of cycles administered and when given with concomitant radiation therapy.
Infusion-related reaction (IRR):
Stop infusion at first sign of anaphylaxis or severe IRR and manage as per emergency.
Etoposide:
Administer etoposide (irritant):
via IV infusion over 30 to 60 minutes
flush with ~ 100 mL sodium chloride 0.9%.
Infusion-related reaction (IRR)
Stop infusion at first sign of anaphylaxis or severe IRR and manage as per emergency.